Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

NCT01587651 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Prasugrel Loading Dose
DRUG: Prasugrel Maintenance Dose
DRUG: Ticagrelor Maintenance Dose

Sponsor

Daiichi Sankyo

Collaborators

[object Object]